Literature DB >> 12422936

The serotonergic system and mysticism: could LSD and the nondrug-induced mystical experience share common neural mechanisms?

Neil Goodman1.   

Abstract

This article aims to explore, through established scientific research and documented accounts of personal experience, the similarities between religious mystical experiences and some effects of D-lysergic diethylamide or LSD. LSD predominantly works upon the serotonergic (serotonin-using neurons) diffuse neuromodulatory system, which projects its axons to virtually all areas of the brain including the neocortex. By its normal action it modulates awareness of the environmental surroundings and filters a high proportion of this information before it can be processed, thereby only allowing the amount of information that is necessary for survival. LSD works to open this filter, and so an increased amount of somatosensory data is processed with a corresponding increase in what is deemed important. This article describes the effects and actions of LSD, and due to the similarities with the nondrug-induced mystical experience the author proposes that the two could have common modes of action upon the brain. This could lead to avenues of research into mysticism and a wealth of knowledge on consciousness and how we perceive the universe.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12422936     DOI: 10.1080/02791072.2002.10399962

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  5 in total

1.  Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.

Authors:  Alexander V Lebedev; Martin Lövdén; Gidon Rosenthal; Amanda Feilding; David J Nutt; Robin L Carhart-Harris
Journal:  Hum Brain Mapp       Date:  2015-05-22       Impact factor: 5.038

2.  Neuroanatomical correlates of familial risk-for-depression and religiosity/spirituality.

Authors:  Connie Svob; Jie Liu; Priya Wickramaratne; Xuejun Hao; Ardesheer Talati; Jürgen Kayser; Craig Tenke; Virginia Warner; Jie Yang; Micheline Anderson; Myrna M Weissman
Journal:  Spiritual Clin Pract (Wash D C )       Date:  2017-03

3.  Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI).

Authors:  Matthew M Nour; Lisa Evans; David Nutt; Robin L Carhart-Harris
Journal:  Front Hum Neurosci       Date:  2016-06-14       Impact factor: 3.169

Review 4.  d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.

Authors:  Danilo De Gregorio; Stefano Comai; Luca Posa; Gabriella Gobbi
Journal:  Int J Mol Sci       Date:  2016-11-23       Impact factor: 5.923

5.  MDMA-Induced Dissociative State not Mediated by the 5-HT2A Receptor.

Authors:  Drew J Puxty; Johannes G Ramaekers; Rafael de la Torre; Magí Farré; Neus Pizarro; Mitona Pujadas; Kim P C Kuypers
Journal:  Front Pharmacol       Date:  2017-07-11       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.